Cargando…

Development and External Validation of a PET Radiomic Model for Prognostication of Head and Neck Cancer

SIMPLE SUMMARY: A lack of external validation is still one of the major limitations of radiomics, hampering its clinical translation. The aim of this study was to build and externally validate an [(18)F]FDG PET radiomic model to predict overall survival in patients with head and neck squamous cell c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Noortman, Wyanne A., Aide, Nicolas, Vriens, Dennis, Arkes, Lisa S., Slump, Cornelis H., Boellaard, Ronald, Goeman, Jelle J., Deroose, Christophe M., Machiels, Jean-Pascal, Licitra, Lisa F., Lhommel, Renaud, Alessi, Alessandra, Woff, Erwin, Goffin, Karolien, Le Tourneau, Christophe, Gal, Jocelyn, Temam, Stéphane, Delord, Jean-Pierre, van Velden, Floris H. P., de Geus-Oei, Lioe-Fee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216021/ https://www.ncbi.nlm.nih.gov/pubmed/37345017 http://dx.doi.org/10.3390/cancers15102681

Ejemplares similares

Adding the temporal domain to PET radiomic features
por: Noortman, Wyanne A., et al.
Publicado: (2020)

[(18)F]FDG-PET/CT radiomics for the identification of genetic clusters in pheochromocytomas and paragangliomas
por: Noortman, Wyanne A., et al.
Publicado: (2022)

The Influence of the Exclusion of Central Necrosis on [(18)F]FDG PET Radiomic Analysis
por: Noortman, Wyanne A., et al.
Publicado: (2021)

Quantitative classification and radiomics of [(18)F]FDG-PET/CT in indeterminate thyroid nodules
por: de Koster, Elizabeth J., et al.
Publicado: (2022)

Methodological considerations in quantification of oncological FDG PET studies
por: Vriens, Dennis, et al.
Publicado: (2009)

FDG-PET/CT based response-adapted treatment
por: de Geus-Oei, Lioe-Fee, et al.
Publicado: (2012)

Bone Metastases Are Measurable: The Role of Whole-Body MRI and Positron Emission Tomography
por: Oprea-Lager, Daniela E., et al.
Publicado: (2021)

Predictive and prognostic value of FDG-PET
por: de Geus-Oei, Lioe-Fee, et al.
Publicado: (2008)

Editorial on Special Issue “Quantitative PET and SPECT”
por: van Velden, Floris H. P., et al.
Publicado: (2022)

FDG-PET/CT in indeterminate thyroid nodules: cost-utility analysis alongside a randomised controlled trial
por: de Koster, Elizabeth J., et al.
Publicado: (2022)

Denosumab Reduces Lesional Fluoride Skeletal Burden on Na[(18)F]F PET-CT in Patients With Fibrous Dysplasia/McCune–Albright Syndrome
por: van der Bruggen, Wouter, et al.
Publicado: (2021)

Radioiodine in Differentiated Thyroid Carcinoma: Do We Need Diagnostic Pre-Ablation Iodine-123 Scintigraphy to Optimize Treatment?
por: de Koster, Elizabeth J., et al.
Publicado: (2021)

How to attract young talent to nuclear medicine step 1: a survey conducted by the EANM Oncology and Theranostics Committee to understand the expectations of the next generation
por: Ambrosini, Valentina, et al.
Publicado: (2023)

Immunotherapy response evaluation with (18)F-FDG-PET in patients with advanced stage renal cell carcinoma
por: Gilles, Rozemarie, et al.
Publicado: (2011)

Experimental validation of absolute SPECT/CT quantification for response monitoring in patients with coronary artery disease
por: van de Burgt, Alina, et al.
Publicado: (2021)

PET/CT in Patients with Breast Cancer Treated with Immunotherapy
por: Vaz, Sofia C., et al.
Publicado: (2023)

Prostate-specific membrane antigen (PSMA) as a potential target for molecular imaging and treatment in bone and soft tissue sarcomas
por: Kleiburg, Fleur, et al.
Publicado: (2023)

Striatal dopamine synthesis capacity in autism spectrum disorder and its relation with social defeat: an [(18)F]-FDOPA PET/CT study
por: Schalbroeck, Rik, et al.
Publicado: (2021)

A clinically applicable molecular classification of oncocytic cell thyroid nodules
por: de Koster, Elizabeth J, et al.
Publicado: (2023)

Impact of the COVID-19 crisis on imaging in oncological trials
por: Deroose, Christophe M., et al.
Publicado: (2020)

Prognostic Value of [(18)F]FDG PET Radiomics to Detect Peritoneal and Distant Metastases in Locally Advanced Gastric Cancer—A Side Study of the Prospective Multicentre PLASTIC Study
por: Pullen, Lieke C. E., et al.
Publicado: (2023)

[(18)F]FDG Uptake and Expression of Immunohistochemical Markers Related to Glycolysis, Hypoxia, and Proliferation in Indeterminate Thyroid Nodules
por: de Koster, Elizabeth J., et al.
Publicado: (2022)

Ablation margin quantification after thermal ablation of malignant liver tumors: How to optimize the procedure? A systematic review of the available evidence
por: Hendriks, Pim, et al.
Publicado: (2023)

Cerebral [(18)F]-FDOPA Uptake in Autism Spectrum Disorder and Its Association with Autistic Traits
por: Schalbroeck, Rik, et al.
Publicado: (2021)

Health-related quality of life following FDG-PET/CT for cytological indeterminate thyroid nodules
por: de Koster, Elizabeth J, et al.
Publicado: (2022)

Reinducing Radioiodine-Sensitivity in Radioiodine-Refractory Thyroid Cancer Using Lenvatinib (RESET): Study Protocol for a Single-Center, Open Label Phase II Trial
por: Dotinga, Maaike, et al.
Publicado: (2022)

Peptide Receptor Radionuclide Therapy Targeting the Somatostatin Receptor: Basic Principles, Clinical Applications and Optimization Strategies
por: Ahmadi Bidakhvidi, Niloefar, et al.
Publicado: (2021)

Molecular Targeted Positron Emission Tomography Imaging and Radionuclide Therapy of Pancreatic Ductal Adenocarcinoma
por: Poels, Thomas T., et al.
Publicado: (2021)

The current role of nuclear medicine in breast cancer
por: Vaz, Sofia C., et al.
Publicado: (2023)

Baseline and early digital [(18)F]FDG PET/CT and multiparametric MRI contain promising features to predict response to neoadjuvant therapy in locally advanced rectal cancer patients: a pilot study
por: Vuijk, Floris A., et al.
Publicado: (2023)

Treatment outcome and toxicity of intensity-modulated (chemo) radiotherapy in stage III non-small cell lung cancer patients
por: Govaert, Stephanie LA, et al.
Publicado: (2012)

[(18)F]FDG-PET/CT to prevent futile surgery in indeterminate thyroid nodules: a blinded, randomised controlled multicentre trial
por: de Koster, Elizabeth J., et al.
Publicado: (2022)

Fludeoxyglucose positron emission tomography-computed tomography scan showing polyarthritis in a patient with an atypical presentation of Henoch-Schönlein vasculitis without clinical signs of arthritis: a case report
por: Mooij, Christiaan F., et al.
Publicado: (2016)

Nanocarriers as a Tool for the Treatment of Colorectal Cancer
por: C. de S. L. Oliveira, Ana Luiza, et al.
Publicado: (2021)

Rationale and design of LUX-Head & Neck 1: a randomised, Phase III trial of afatinib versus methotrexate in patients with recurrent and/or metastatic head and neck squamous cell carcinoma who progressed after platinum-based therapy
por: Machiels, Jean-Pascal H, et al.
Publicado: (2014)

FDG-PET in colorectal cancer
por: de Geus-Oei, Lioe-Fee, et al.
Publicado: (2006)

Quantitative Volumetric Assessment of Ablative Margins in Hepatocellular Carcinoma: Predicting Local Tumor Progression Using Nonrigid Registration Software
por: Hendriks, P., et al.
Publicado: (2019)

The role of (18)F-FDG PET in the differentiation between lung metastases and synchronous second primary lung tumours
por: Dijkman, Bernadette G., et al.
Publicado: (2010)

Design and evaluation of a modular multimodality imaging phantom to simulate heterogeneous uptake and enhancement patterns for radiomic quantification in hybrid imaging: A feasibility study
por: Kalisvaart, Gijsbert M., et al.
Publicado: (2022)

Value of [(68)Ga]Ga-somatostatin receptor PET/CT in the grading of pulmonary neuroendocrine (carcinoid) tumours and the detection of disseminated disease: single-centre pathology-based analysis and review of the literature
por: Deleu, Anne-Leen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8kcjhl8a92hig78cmpc5leu5ft